10 likes | 107 Views
The brain cancer EpiCast Report provides an overview of the risk factors, comorbidities, and the global and historical trends for brain cancer in the seven major markets. <br>For more info: http://bit.ly/1LSHfcO
E N D
REFERENCE CODE GDHCER106-15 | PUBLICATION DATE DECEMBER 2015 Brain Cancer – Epidemiology Forecast To 2024 Channel sales partner 7MM, Five-Year Diagnosed Prevalent Cases of Brain Cancer, All Ages, Both Sexes, N, 2014 and 2024 89,984 7MM 84,704 46,401 US 42,104 36,148 5EU 34,868 11,038 Germany 11,180 8,307 Market France 7,929 7,435 Japan 7,732 6,330 2024 2014 Italy 6,044 5,897 UK 5,558 4,576 Spain 4,157 0 20,000 Five-Year Diagnosed Prevalent Cases (N) 40,000 60,000 80,000 Source: GlobalData; Cancer Research UK, 2014b; CCCIS, NCC, 2011; Ferlay et al., 2014; Howlader et al., 2014; ITACAN, 2014; ZfKD, 2014 5EU = France, Germany, Italy, Spain, and UK; 7MM = US, 5EU, and Japan This report provides an overview of the risk factors, comorbidities, and the global and historical trends for brain cancer in the seven major markets (7MM) (US, France, Germany, Italy, Spain, UK, and Japan). In the 7MM, GlobalData epidemiologists forecast that the diagnosed incident cases of brain cancer will increase from 55,084 cases in 2014 to 62,226 cases in 2024, at an Annual Growth Rate (AGR) of 1.30%. The US will have the highest number of diagnosed incident cases of brain cancer among the 7MM throughout the forecast period. The five-year diagnosed prevalent cases of brain cancer are also expected to increase from 84,704 cases in 2014 to 89,984 cases in 2024, at an AGR of 0.62%. click to purchase -http://www.jsbmarketresearch.com/healthcare-medical/r-epicast-report-brain-cancer-epidemiology-forecast-to-2024-234934 © GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form.